Congress is under considerable pressure to
address the absence of outpatient prescription drug coverage in
Medicare, the huge and financially troubled program that covers
almost 40 million elderly and disabled Americans. Several bills
before Congress would attempt to do this. For example, S. 841,
sponsored by Senator Edward Kennedy (D-MA), and its companion bill,
H.R. 1495, sponsored by Representative Pete Stark (D-CA), would
require the Secretary of the U.S. Department of Health and Human
Services (HHS) to contract with benefit managers, retail
pharmacies, insurers, and others to provide a prescription drug
benefit to Medicare's beneficiaries.
The
real task before Congress, however, is not so much whether to
provide prescription drug coverage to Medicare beneficiaries, but
rather how to assist those seniors who really need help in
obtaining prescription drugs, and how to finance it--considering
the enormous potential cost of such coverage and the poor track
record of previous attempts to add it. There is concern that
congressional "remedies" could lead to a disruption of the
prescription drug market and undermine the quality and availability
of the very benefit lawmakers hope to provide. Members of Congress
should recognize that:
- Medicare is already in financial trouble,
and the addition of a costly new benefit, especially if done
poorly, could make its financial condition worse;
- A new prescription drug benefit would
likely increase Medicare costs dramatically; and
- Seniors could see their Medicare premiums
double, and could find themselves with duplicate coverage.
Before providing a prescription drug
benefit to Medicare beneficiaries, Congress should determine how
many senior citizens are experiencing difficulty in obtaining
prescription drugs. Although nearly 9 out of 10 Medicare
beneficiaries use prescription drugs, according to Bureau of Labor
Statistics data for 1997, the average senior spent $637 annually on
both prescription and non-prescription drugs--less than what the
poorest seniors report spending in restaurants. A study for the
National Academy of Social Insurance reports that only 10 percent
of seniors have annual out-of-pocket expenditures for prescription
drugs of $1,000 to $2,000, and only 4 percent report spending more
than $2,000. The problem of affordability for a relatively small
number of seniors is not a systemic crisis that necessitates a
complete overhaul of the system.
Congress has considered adding a
prescription drug benefit in the past. In 1988, with overwhelming
support from the public and various interest groups, Congress
enthusiastically passed the Medicare Catastrophic Coverage Act,
adding a range of generous new benefits to the Medicare program
that included coverage for outpatient prescription drugs. Within
weeks, Congress was inundated with letters and calls from outraged
seniors as they became aware of the ways in which this new law
would impact their pocketbooks. Within one year, the Congressional
Budget Office's estimates for the cost of the prescription drug
benefit skyrocketed from $5.7 billion to $11.8 billion. By late
1989, under a powerful backlash from seniors, Congress was forced
to repeal major elements of the law.
One
of the proposals before Congress, S. 841 (H.R. 1495) requires the
Department of HHS to contract with benefit managers, retail
pharmacies, and insurers to provide a managed prescription drug
benefit to Medicare beneficiaries. This approach, however, would
jeopardize the supplemental drug coverage currently enjoyed by
two-thirds of America's seniors, diminish the incentives seniors
have to purchase Medigap or Medicare health maintenance
organization policies, and make employers less likely to offer
private health plans to their elderly employees. Not only is such a
proposal bad policy, but its price tag of $20 billion, as estimated
by Senator Kennedy when he introduced his bill, is likely to be a
gross underestimate of the actual costs.
To
assist lower-income seniors to obtain their prescription drugs,
Congress should consider implementing the following steps:
- Establish a Medicare prescription drug
benefit in Medicare managed care plans based on the procedure used
in the Federal Employees Health Benefits Program (FEHBP).
Nearly all the plans offered federal employees in the FEHBP
include a prescription drug benefit even without a mandate to do
so.
- Create a "Benefits Board" to determine
how to include a drug benefit in the Medicare fee-for-service
program.
Congress then could vote straight up or down on the board's annual
recommendations.
- Create an independent "Medicare Board"
to negotiate on behalf of seniors for prescription drug benefits as
well as other benefits.
This board should be modeled after the Office of Personnel
Management, which negotiates with private insurance companies on
behalf of federal workers for prescription drugs and other benefits
in the FEHBP.
- Establish a voucher system to assist
lower-income seniors to pay for prescription drugs.
The federal government gives the poor vouchers (food stamps) to
purchase food of their choice in a freely functioning market.
Medicare could provide similar vouchers for prescription drugs.
- Create a Medigap option exclusively for
prescription drugs.
There currently are 10 types of Medigap policies available to
seniors. Only three include prescription drug coverage, and none is
for drugs alone. Congress should develop one or more new Medigap
plans for prescription drugs.
The
majority of seniors does not experience problems in obtaining
medication. Targeting those that do would cost taxpayers far less
than providing 40 million Medicare beneficiaries with coverage that
may duplicate their existing coverage. Members of Congress should
allow senior citizens the same choices they themselves enjoy under
the FEHBP and avoid mistakes Congress made in the past. In short,
Members of Congress should not promise low-cost prescription drugs
that they cannot deliver.
James
Frogue is a former Health Care Policy Analyst at The Heritage
Foundation.